Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structure-from-motion in micro-image domain for uncalibrated plenoptic 2.0 cameras.

International journal of computer vision·2026

Same author

Neuro-cognitive specificities in prosocial disobedience: A comparative fMRI study of civilian and military populations.

PloS one·2025

Same author

Liver Fibrosis: Diving into Microstructure with Diffusion-weighted Imaging.

Radiology·2024

Same author

Editorial for "The Use of Diffusion Tensor Imaging in the Identification of Acute Rejection and Chronic Allograft Nephropathy After Renal Transplantation".

Journal of magnetic resonance imaging : JMRI·2023

Same author

Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model.

Molecular cancer therapeutics·2023

Same author

Can quantified diffusion-weighted imaging predict histopathological features of liver tumors?

European radiology·2023

Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026

Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026

Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026

Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026

Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026

Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 21, 2025

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Deep Learning for Reaction-Diffusion Glioma Growth Modeling: Towards a Fully Personalized Model?

Corentin Martens^1,2,3, Antonin Rovai¹, Daniele Bonatto³

¹Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium.

|May 28, 2022

Summary

This summary is machine-generated.

Deep convolutional neural networks (DCNNs) can now reconstruct brain tumor growth and estimate model parameters using limited imaging data. This advances personalized glioma prognosis and treatment planning.

Keywords:

cellularity deep convolutional neural network glioma magnetic resonance imaging reaction-diffusion model tumor growth modeling

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Related Experiment Videos

Last Updated: Sep 21, 2025

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Translational Orthotopic Models of Glioblastoma Multiforme

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Area of Science:

Computational biology
Medical imaging
Artificial intelligence

Background:

Reaction-diffusion models are used for glioma growth but face challenges with initialization and parameter estimation for clinical use.
Personalized prediction of brain tumor progression remains a significant challenge in oncology.

Purpose of the Study:

To investigate the efficacy of deep convolutional neural networks (DCNNs) in overcoming limitations of reaction-diffusion models for glioma.
To enable accurate reconstruction of tumor cell density and estimation of model parameters using limited magnetic resonance (MR) data.

Main Methods:

Trained DCNNs on 1200 synthetic tumors grown on real brain geometries from MR data.
Validated DCNNs' ability to reconstruct tumor distribution from two imaging contours.
Assessed DCNNs' capability to estimate diffusivity and proliferation parameters with an additional prior time point contour.

Main Results:

DCNNs successfully reconstructed whole tumor cell-density distributions from minimal imaging data.
Accurate estimation of individual tumor model parameters (diffusivity, proliferation) was achieved.
Demonstrated precise capture of spatio-temporal tumor evolution and applicability to real glioblastoma patient MR data.

Conclusions:

DCNNs offer a robust solution to initialization and parameter estimation issues in reaction-diffusion glioma models.
This approach facilitates personalized tumor prognosis and treatment planning by enabling accurate prediction of glioma evolution.
The study paves the way for clinical integration of advanced computational models in neuro-oncology.